Daniela Schneider
Overview
Explore the profile of Daniela Schneider including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
340
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cologni R, Holschbach M, Schneider D, Bier D, Schulze A, Stegmayr C, et al.
Molecules
. 2024 Aug;
29(16).
PMID: 39203017
Mutations of isocitrate dehydrogenase 1 (IDH1) are key biomarkers for glioma classification, but current methods for detection of mutated IDH1 (mIDH1) require invasive tissue sampling and cannot be used for...
2.
Humpert S, Schneider D, Bier D, Schulze A, Neumaier F, Neumaier B, et al.
Eur J Med Chem
. 2024 Apr;
271:116380.
PMID: 38615410
Imaging of the A adenosine receptor (AR) by positron emission tomography (PET) with 8-cyclopentyl-3-(3-[F]fluoropropyl)-1-propyl-xanthine ([F]CPFPX) has been widely used in preclinical and clinical studies. However, this radioligand suffers from rapid...
3.
Humpert S, Schneider D, Lang M, Schulze A, Neumaier F, Holschbach M, et al.
Molecules
. 2024 Mar;
29(5).
PMID: 38474602
Tozadenant (4-hydroxy--(4-methoxy-7-morpholinobenzo[]thiazol-2-yl)-4-methylpiperidine-1-carboxamide) is a highly selective adenosine A receptor (AR) antagonist and a promising lead structure for the development of AR-selective positron emission tomography (PET) probes. Although several F-labelled tozadenant...
4.
Montero D, Garcia-Betancourt R, Vidal R, Velasco J, Palacios P, Schneider D, et al.
Front Immunol
. 2023 Aug;
14:1186368.
PMID: 37575242
Background: Shiga toxin-producing (STEC) is a foodborne pathogen that causes gastrointestinal infections, ranging from acute diarrhea and dysentery to life-threatening diseases such as Hemolytic Uremic Syndrome. Currently, a vaccine to...
5.
Pother D, Schneider D, Prott U, Karmann J, Klug K, Heubach N, et al.
Ann Work Expo Health
. 2021 Jul;
65(9):1061-1074.
PMID: 34219143
Anaerobic digestion is an emerging technology producing energy from renewable resources or food waste. Exposure screenings, comprising hazardous substances and biological agents, at different workplaces are necessary for a comprehensive...
6.
Schneider D, Bier D, Holschbach M, Bauer A, Neumaier B
Pharmaceuticals (Basel)
. 2021 Apr;
14(3).
PMID: 33803861
Tracer development for positron emission tomography (PET) requires thorough evaluation of pharmacokinetics, metabolism, and dosimetry of candidate radioligands in preclinical animal studies. Since variations in pharmacokinetics and metabolism of a...
7.
Valdes G, Acuna S, Schneider D, Ortiz R, Padilla O
Reprod Sci
. 2020 May;
27(8):1648-1655.
PMID: 32430711
Introduction: The pleiotropic kininogen-kallikrein-kinin system is upregulated in pregnancy and localizes in the uteroplacental unit. To identify the systemic and local participation of the bradykinin type 2 receptor (B2R), this...
8.
Redoute Minziere V, Werner D, Schneider D, Manganelli M, Jung B, Weyermann C, et al.
J Forensic Sci
. 2020 Mar;
65(4):1102-1113.
PMID: 32181891
Gunshot residue (GSR) analysis and their interpretation provide crucial information on a criminal investigation involving the use of firearms. To date, several approaches have been proposed for the implementation of...
9.
Schneider D, Oskamp A, Holschbach M, Neumaier B, Bier D, Bauer A
Nucl Med Biol
. 2019 Dec;
82-83:1-8.
PMID: 31838339
Introduction: The suitability of novel positron emission tomography (PET) radioligands for quantitative in vivo imaging is affected by various physicochemical and pharmacological parameters. In this study, the combined effect of...
10.
Schneider D, Oskamp A, Holschbach M, Neumaier B, Bauer A, Bier D
Pharmaceuticals (Basel)
. 2019 Apr;
12(2).
PMID: 31013984
The prediction of in vivo clearance from in vitro metabolism models such as liver microsomes is an established procedure in drug discovery. The potentials and limitations of this approach have...